Call for female healthcare scientists to apply for NHS England leadership scheme

The role of women in the NHS in England

This International Women’s Day, NHS Digital has published an analysis of the role of women in the NHS in England. Women account for more than...
Public satisfaction with the NHS has fallen to its lowest level since 2007

Public satisfaction with the NHS falls to lowest level

Public satisfaction with the NHS has fallen to its lowest level since 2007, according to analysis of the 2018 British Social Attitudes (BSA) survey published today by...
More people will be eligible for cochlear implants

More people are eligible for cochlear implants with NICE guidance

Hundreds more people with severe to profound deafness will be eligible for cochlear implants each year, due to updated final NICE guidance published today. The update...
HIV remission achieved in a second patient

HIV remission achieved in a second patient

A case, published in Nature and carried out by scientists at University College London, Imperial College London, the University of Cambridge and the University of Oxford has...
chronic lung disease

New clues as to why non-smokers develop chronic lung disease

MRC-funded researchers led by the Universities of Leicester and Nottingham have discovered genetic differences that put some people at higher risk than others of...

Outcome-based payment for cancer drugs could accelerate treatment

Outcome-based payment for cancer drugs based on how well they work in practice could get patients new treatments faster, according to a Cancer Research...
Ipad and the cloud: NHSX

NHSX: Combining the best talent from government, the NHS and industry

A new joint unit, NHSX, will be created to bring the benefits of modern technology to every patient and clinician. It will combine the...
Trial results of Brilinta for heart attack patients following thrombolysis shows it met safety endpoint in secondary analysis of Phase III TREAT trial

Health matters: preventing cardiovascular disease

The Department of Health and Social Care has published a new professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation,...
Dementia drug discovery consortium

New partners join £9.5 million dementia drug discovery collaboration

The Dementia Consortium welcomes Johnson & Johnson Innovation, Takeda and Evotec to join the unique £9.5 million dementia drug discovery collaboration. This second phase...
antibiotic prescribing guidance

New antibiotic prescribing guidance for patients with suspected pneumonia 

The National Institute for Health and Care Excellence and Public Health England have published new antibiotic prescribing guidance for patients with suspected pneumonia. These...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...